Paul, Judy and All -
I quite agree that the party is just beginning. And what a party it will be! In particular, our new management can throw a party that is so different from -- and so much better than -- what the old, deposed and discredited management could throw. Here's what I mean.
1. Rhodes & the Rhodies seemed to believe that, if we saw some promising results from a compound in our TCM library, people would bring buckets of cash to the Company. It didn't happen, of course. Bernie has an actual business plan, and real partners, with real cash. Both Roswell Park and Southern Research Institute have experience in patenting, clinical trials, and FDA drug approval. Instead of waiting around for something to happen (which never did), we have Roswell and SRI scientists partnering with Paracelsian scientists, moving forward on drug development.
2. Rhodes & the Rhodies relied upon Dow to market Ah-Immunoassay - which they didn't. Bernie is executing a business plan to market that product. As we know from the audio interview, and the 10KSB, a deal is likely in the very near future. Revenues flow into PRLN.
3. BioFIT is all Bernie's. The revenues support ongoing operations. The impact on the stock awaits Scherer, I believe: when THEY (and not us) claim publicly that this is the correct route to assuring bioactivity, and quality, the stock will react.
My view of our world,
Jonathan
|
